155 related articles for article (PubMed ID: 19276075)
1. The second transmembrane domain of the human type 1 angiotensin II receptor participates in the formation of the ligand binding pocket and undergoes integral pivoting movement during the process of receptor activation.
Domazet I; Holleran BJ; Martin SS; Lavigne P; Leduc R; Escher E; Guillemette G
J Biol Chem; 2009 May; 284(18):11922-9. PubMed ID: 19276075
[TBL] [Abstract][Full Text] [Related]
2. The fifth transmembrane domain of angiotensin II Type 1 receptor participates in the formation of the ligand-binding pocket and undergoes a counterclockwise rotation upon receptor activation.
Domazet I; Martin SS; Holleran BJ; Morin ME; Lacasse P; Lavigne P; Escher E; Leduc R; Guillemette G
J Biol Chem; 2009 Nov; 284(46):31953-61. PubMed ID: 19773549
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the third transmembrane domain of the human type 1 angiotensin II receptor by cysteine scanning mutagenesis.
Martin SS; Boucard AA; Clément M; Escher E; Leduc R; Guillemette G
J Biol Chem; 2004 Dec; 279(49):51415-23. PubMed ID: 15452107
[TBL] [Abstract][Full Text] [Related]
4. Analysis of transmembrane domains 1 and 4 of the human angiotensin II AT1 receptor by cysteine-scanning mutagenesis.
Yan L; Holleran BJ; Lavigne P; Escher E; Guillemette G; Leduc R
J Biol Chem; 2010 Jan; 285(4):2284-93. PubMed ID: 19940150
[TBL] [Abstract][Full Text] [Related]
5. Activation of the angiotensin II type 1 receptor leads to movement of the sixth transmembrane domain: analysis by the substituted cysteine accessibility method.
Martin SS; Holleran BJ; Escher E; Guillemette G; Leduc R
Mol Pharmacol; 2007 Jul; 72(1):182-90. PubMed ID: 17446269
[TBL] [Abstract][Full Text] [Related]
6. Constitutive activation of the angiotensin II type 1 receptor alters the spatial proximity of transmembrane 7 to the ligand-binding pocket.
Boucard AA; Roy M; Beaulieu ME; Lavigne P; Escher E; Guillemette G; Leduc R
J Biol Chem; 2003 Sep; 278(38):36628-36. PubMed ID: 12842881
[TBL] [Abstract][Full Text] [Related]
7. Identification of transmembrane domain 6 & 7 residues that contribute to the binding pocket of the urotensin II receptor.
Holleran BJ; Domazet I; Beaulieu ME; Yan LP; Guillemette G; Lavigne P; Escher E; Leduc R
Biochem Pharmacol; 2009 Apr; 77(8):1374-82. PubMed ID: 19426676
[TBL] [Abstract][Full Text] [Related]
8. Identification of transmembrane domain 3, 4 & 5 residues that contribute to the formation of the ligand-binding pocket of the urotensin-II receptor.
Sainsily X; Cabana J; Boulais PE; Holleran BJ; Escher E; Lavigne P; Leduc R
Biochem Pharmacol; 2013 Dec; 86(11):1584-93. PubMed ID: 24084430
[TBL] [Abstract][Full Text] [Related]
9. Analysis by substituted cysteine scanning mutagenesis of the fourth transmembrane domain of the CXCR4 receptor in its inactive and active state.
Boulais PE; Escher E; Leduc R
Biochem Pharmacol; 2013 Feb; 85(4):541-50. PubMed ID: 23219524
[TBL] [Abstract][Full Text] [Related]
10. Long range effect of mutations on specific conformational changes in the extracellular loop 2 of angiotensin II type 1 receptor.
Unal H; Jagannathan R; Bhatnagar A; Tirupula K; Desnoyer R; Karnik SS
J Biol Chem; 2013 Jan; 288(1):540-51. PubMed ID: 23139413
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the amino acid residues in the sixth transmembrane domains accessible in the binding-site crevices of mu, delta, and kappa opioid receptors.
Xu W; Li J; Chen C; Huang P; Weinstein H; Javitch JA; Shi L; de Riel JK; Liu-Chen LY
Biochemistry; 2001 Jul; 40(27):8018-29. PubMed ID: 11434771
[TBL] [Abstract][Full Text] [Related]
12. Identification of transmembrane domain 1 & 2 residues that contribute to the formation of the ligand-binding pocket of the urotensin-II receptor.
Sainsily X; Cabana J; Holleran BJ; Escher E; Lavigne P; Leduc R
Biochem Pharmacol; 2014 Nov; 92(2):280-8. PubMed ID: 25175740
[TBL] [Abstract][Full Text] [Related]
13. Structure and dynamics of the GABA binding pocket: A narrowing cleft that constricts during activation.
Wagner DA; Czajkowski C
J Neurosci; 2001 Jan; 21(1):67-74. PubMed ID: 11150321
[TBL] [Abstract][Full Text] [Related]
14. Activation induces structural changes in the liganded angiotensin II type 1 receptor.
Clément M; Cabana J; Holleran BJ; Leduc R; Guillemette G; Lavigne P; Escher E
J Biol Chem; 2009 Sep; 284(39):26603-12. PubMed ID: 19635801
[TBL] [Abstract][Full Text] [Related]
15. Cysteine 2.59(89) in the second transmembrane domain of human CB2 receptor is accessible within the ligand binding crevice: evidence for possible CB2 deviation from a rhodopsin template.
Zhang R; Hurst DP; Barnett-Norris J; Reggio PH; Song ZH
Mol Pharmacol; 2005 Jul; 68(1):69-83. PubMed ID: 15840841
[TBL] [Abstract][Full Text] [Related]
16. The active and the inactive form of the hAT1 receptor have an identical ligand-binding environment: an MPA study on a constitutively active angiotensin II receptor mutant.
Clément M; Chamberland C; Pérodin J; Leduc R; Guillemette G; Escher E
J Recept Signal Transduct Res; 2006; 26(5-6):417-33. PubMed ID: 17118790
[TBL] [Abstract][Full Text] [Related]
17. The conserved cysteine 7.38 residue is differentially accessible in the binding-site crevices of the mu, delta, and kappa opioid receptors.
Xu W; Chen C; Huang P; Li J; de Riel JK; Javitch JA; Liu-Chen LY
Biochemistry; 2000 Nov; 39(45):13904-15. PubMed ID: 11076532
[TBL] [Abstract][Full Text] [Related]
18. Chloroethylclonidine and 2-aminoethyl methanethiosulfonate recognize two different conformations of the human alpha(2A)-adrenergic receptor.
Marjamäki A; Frang H; Pihlavisto M; Hoffrén AM; Salminen T; Johnson MS; Kallio J; Javitch JA; Scheinin M
J Biol Chem; 1999 Jul; 274(31):21867-72. PubMed ID: 10419505
[TBL] [Abstract][Full Text] [Related]
19. Constitutive activation of the beta2 adrenergic receptor alters the orientation of its sixth membrane-spanning segment.
Javitch JA; Fu D; Liapakis G; Chen J
J Biol Chem; 1997 Jul; 272(30):18546-9. PubMed ID: 9228019
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of constitutive activity: mutations at position 111 of the angiotensin AT1 receptor.
Nikiforovich GV; Mihalik B; Catt KJ; Marshall GR
J Pept Res; 2005 Nov; 66(5):236-48. PubMed ID: 16218991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
